Navigation Links
Leading neuroscientist seeks beauty, love and happiness
Date:11/13/2007

One of the world's leading neuroscientists is to search for the neural and biological basis for creativity, beauty and love after receiving over 1 million from the Wellcome Trust, the UK's largest medical research charity. The research will bring together science, the arts and philosophy to answer fundamental questions about what it means to be human.

Professor Semir Zeki from University College London (UCL) has received a Wellcome Trust Strategic Award to establish a programme of research in the new field of "neuroaesthetics". The research will build on his previous work into the neural mechanisms behind beauty(1) and love(2).

Together with Professor Ray Dolan, Director of the Wellcome Trust Centre for Neuroimaging at UCL, Professor Zeki will look at questions that have been debated for millennia by writers, artists and philosophers and yet have been little studied by neurobiologists: Can we measure beauty objectively" How are beauty and love related" What does it mean to be happy"

"All human societies place a high premium on art and the pursuit of beauty," says Professor Zeki. "We all value and reward creativity. We all want to pursue happiness. But what do these entities mean in concrete, neurobiological terms" We hope to address these issues experimentally. The results will not only increase our knowledge about the workings of the human brain but will also give deep insights into human nature and how we view ourselves."

Neuroesthetics aims to illuminate the brain's workings through its cultural products in a similar way to how neuroscientists study the brain through malfunctions caused by disease. However, Professor Zeki believes its impact may be much wider.

"The new field of neuroaesthetics will teach biologists to use the products of the brain in art, music, literature and mathematics to better understand how the brain functions," he says. "Success will encourage an interdisciplinary approach to other fields, such as the study of economics or jurisprudence in terms of brain activity. This will have a deep impact on social issues."

Using Wellcome Trust funding, Professor Zeki hopes to attract students and researchers from the sciences, arts and humanities in truly interdisciplinary research. Their work will be overseen by an Advisory Board that will include author AS Byatt, physician, opera producer and broadcaster Sir Jonathan Miller and Dr. Deborah Swallow, Director of the Courtauld Institute of Art, London.

"Professor Zeki is a Renaissance Man for the twenty-first century," says Professor Richard Morris, Head of Neurosciences and Mental Health at the Wellcome Trust. "His research sees no boundaries between science and the arts and humanities and will provide an exciting insight in issues that strike at the heart of what it is to be human."


'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... ... The weather is heating up and the days are getting longer, providing ... that the summer months provide more than warmer temperatures that are perfect for BBQ’s ... affected from direct exposure to the sun. When it comes to the security of ...
(Date:6/23/2017)... Beach, CA (PRWEB) , ... June 23, 2017 , ... ... has earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, ... in the top 1% of all charities reviewed by Charity Navigator and earns ANRF ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... practicing in Newburgh, New York, has recently begun offering three new minimally invasive ... the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited to bring ...
(Date:6/23/2017)... ... , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach ... proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does more ... can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care opened its ... facility overall and marks the urgent care center's eighth location in Miami-Dade county. , ... Falls shopping mall. The new clinic offers a wide array of services ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  StatLab Medical ... developer and manufacturer of diagnostic supplies for ... that Cressey & Company LP ("Cressey & ... completed a growth-focused investment in the Company. ... ownership position from selling shareholder, Prairie Capital, ...
(Date:6/7/2017)... Iowa , June 6, 2017  Diplomat Specialty Infusion Group, ... sterile compounding environment to its Iowa location. ... Urbandale now features an ISO 7 cleanroom—the standard ... controlled environment with a low level of pollutants. ... more IV nutrition consumers and better serve our Iowa ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: